期刊文献+

利用经修饰的survivin短肽体外诱导对胃癌细胞系具有限制性杀伤作用的特异性细胞毒性T细胞

Efficient Induction of Specific Cytotoxic T Lymphocytes Specific to a Kind of Modified Survivin Peptide which Has Restricted Cytotoxicity Against Gastric Cancer Cell Lines in Vitro
下载PDF
导出
摘要 采用一种简单有效的方法体外诱导经修饰的survivin短肽特异性细胞毒性T细胞,并观察其对胃癌细胞的杀伤作用。选取对HLA-A2分子亲和力更高的survivin短肽(96—104,LLLGEFLKL,HLA-A2限制性)以更有效地诱导特异性T细胞。选取正常志愿者外周血单核细胞,筛选其中HLA-A2+者,利用HLA-A2/survivin短肽有效诱导特异性细胞毒性T细胞。Pentamer实验检测特异性细胞毒性T细胞比率。Elispot实验检测细胞毒性T细胞IFN-γ分泌能力。选取胃癌细胞系MKN28、SGC7901及KATO Ⅲ,检测其HLA-A2和survivin表达情况。检测特异性细胞毒性T细胞对三种细胞系的杀伤效果。Pentamer实验结果显示,HLA-A2/survivin短肽刺激之前短肽/HLA Pentamer和CD8双阳性细胞仅为0.06%,接受刺激后双阳性细胞增加到27.5%。Elispot实验结果显示HLA-A2/survivin短肽刺激后IFN-γ分泌细胞比率明显强于阴性对照组。PCR结果显示,KATO Ⅲ为HLA-A2+,MKN28和SGC7901为HLA-A2-。Western Blotting结果显示KATO III和SGC7901为survivin阳性,MKN28为survivin阴性。特异性细胞毒性T细胞杀伤结果显示,细胞能有效杀伤KATO III细胞,但对其他两种细胞杀伤效果不明显。p<0.01。经修饰的survivin短肽能够有效诱导特异性细胞毒性T细胞,并对胃癌细胞系有HLA-A2/survivin限制性杀伤。 A simple and effective method was applied in the present study to induce specific cytotoxic T lym- phocytes via a modified survivin peptide, the cytotoxicity of which is observed against gastric cancer cells. HLA-- A2-restricted survivin peptide (96--104, LLLGEFLKL) used in this study is a modified analogue showing high af- finity to HLA--A2 to ensure the activating effect. Healthy donors with HLA--A2 phenotype are involved and PB- MCs of them are used to induce specific cytotoxic T lymphocytes via HLA--A2/survivin. Pentamer analysis is used to detect the ratio of specific cytotoxic T lymphocytes; Elispot assays to detect the capacity of cytotoxic T lympho- cytes to secrete IFN-~/. Gastric cancer cell lines MKN28, SGC7901, and KATO III are selected and HLA--A2 phenotype and expression of survivin of them are detected. Cytotoxicity of specific cytotoxic T lymphocytes against these gastric cancer cell lines is also detected. Results of Pentamer analysis showed that ratio of peptide/HLA Pen- tamer and CD8 double-positive lymphocytes increased (from 0.06% to 27.5% ) after stimulation. Results of Elis- pot assay showed the average spot number of responding lymphocytes induced by T2 pulsed with survivin/HLA-- A2 peptide is significantly higher than that of responding lymphocytes induced by T2 cells without peptide. Biomar- kers are also detected of KATO III (HLA--A2 +/survivin+ ), MKN28 (HLA--A2/surviving), and SGC7901 (HLA--A2-/survivin + ) via PCR and Western Blotting. Results of cytotoxicity show that the identified CTLs can effectively kill the double-positive cell line (KATO III) but not others(p 〈0. 01 ). Specific CTLs can be induced efficiently via modified survivin peptide and kill gastric cancer ceils with special biomarkers.
出处 《科学技术与工程》 北大核心 2012年第35期9461-9465,共5页 Science Technology and Engineering
基金 国家自然科学基金(81070799)资助
关键词 SURVIVIN 经修饰肽段 HLA-A2 外周血单核细胞 特异性细胞毒性T细胞 胃癌细胞系 survivin modified peptide HLA--A2 PBMCs specific CTLs gastric cancer celllines
  • 相关文献

参考文献15

  • 1Patel P R, YaoJ C,Hess K, et al. Effect of timing of metastasis/dis-ease recurrence and histologic differentiation on survival of patientswith advanced gastric cancer. Cancer,2007 ; 110:2186-2190.
  • 2Ambrosini G, Adida G, Altieri D C. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma. Nat Med, 1997 ; 3 :917-921.
  • 3Storkus W J, Herrem C, Kawabe M,et al. Improving immunotherapyby conditionally enhancing MHC class I presentation of tumor antigenderived Peptide epitopes. Crit Rev Immunol,2007 ; 27 :485-493.
  • 4Novellino L, Castelli C, Parmiani G. A listing of human tumor anti-gens recognized by T cells: March 2004 update. Cancer Immunol Im-munother,2005 ; 54:187-207.
  • 5Caldas H, Honsey L E, Altura R A. Survivin 2alpha: a novel Sur-vivin splice variant expressed in human malignancies. Mol Cancer,Mar,2005 ;4 (1) :11.
  • 6Li F, Role of survivin and its splice variants in tumorigenesis. Br JCancer,2005;92 :212-216.
  • 7Ryan B,ODonovan N,Browne B,et al. Expression of survivin and itssplice variants survivin-2B and survivin-DeltaEx3 in breast cancer. BrJ Cancer, 2005;92:120-124.
  • 8Casati C,Dalerba P,Rivoltini L,et al. The apoptosis inhibitor pro-tein survivin induces tumor-specific CD8 + and CD4 + T cells incolorectal cancer patients. Cancer Res,2003 ;63:4507-4515.
  • 9Andersen M H,Pedersen L 0,Becker J C,et al. Identification of acytotoxic T lymphocyte response to the apoptosis inhibitor protein sur-vivin in cancer patients. Cancer Res,2001 ; 61 :869-872.
  • 10Qiu K, Tomita Y, Hashimoto M, et al. Epstein-Barr virus in gastriccarcinoma in Suzhou, China and Osaka, Japan: association withclinico-pathologic factors and HLA-subtype. Int J Cancer, 1997 ;71:155-158.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部